Related Articles
Antitumor effects of a novel histone deacetylase inhibitor NK-HDAC-1 on breast cancer
Altered histone acetylation patterns in pancreatic cancer cell lines induce subtype‑specific transcriptomic and phenotypical changes
Ritonavir acts synergistically with panobinostat to enhance histone acetylation and inhibit renal cancer growth
FOXO1-mediated epigenetic modifications are involved in the insulin-mediated repression of hepatocyte aquaporin 9 expression
Deficient histone acetylation and excessive deacetylase activity as epigenomic marks of prostate cancer cells